U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187831187831Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Cyclophosphamide|Drug: Docetaxel|Drug: Gemcitabine|Drug: Paclitaxel|Drug: Doxorubicinhttps://ClinicalTrials.gov/show/NCT00093795
187832187832Temsirolimus in Treating Patients With Metastatic Neuroendocrine CarcinomaCompletedNo Results AvailableMetastatic Gastrointestinal Carcinoid Tumor|Pulmonary Carcinoid Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Recurrent Islet Cell CarcinomaDrug: temsirolimus|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00093782
187833187833Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaDrug: bortezomib + rituximabhttps://ClinicalTrials.gov/show/NCT00093769
187834187834Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung CancerCompletedHas ResultsRecurrent Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung CancerRadiation: 3-dimensional conformal radiation therapy|Drug: bortezomib|Drug: paclitaxel|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT00093756
187835187835Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaActive, not recruitingNo Results AvailableAdult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult AcDrug: fludarabine phosphate|Drug: cyclosporine|Radiation: total-body irradiation|Procedure: allogeneic bone marrow transplantation|Procedure: allogeneic hematopoietic stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Drug: mycophenolate mofetilhttps://ClinicalTrials.gov/show/NCT00093743
187836187836BMS-599626 in Treating Patients With Metastatic Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: BMS-59926https://ClinicalTrials.gov/show/NCT00093730
187837187837Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive LymphomaTerminatedNo Results AvailableLymphoma|Lymphoproliferative DisorderDrug: bortezomib + ganciclovirhttps://ClinicalTrials.gov/show/NCT00093704
187838187838Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNo Results AvailableCachexia|Lymphoma|Melanoma (Skin)|Ovarian Cancer|Pain|Sarcoma|Unspecified Adult Solid Tumor, Protocol SpecificDrug: celecoxib|Procedure: anticachectic therapy|Procedure: nutritional support|Procedure: pain therapy|Procedure: supportive care/therapyhttps://ClinicalTrials.gov/show/NCT00093678
187839187839Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal CancerActive, not recruitingNo Results AvailableHead and Neck CancerDrug: cisplatin|Drug: fluorouracil|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00093665
187840187840Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNo Results AvailableEsophageal CancerDrug: gefitinib|Drug: oxaliplatin|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00093652
187841187841Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib MesylateCompletedNo Results AvailableLeukemiaDrug: everolimus|Drug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00093639
187842187842Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal CancerCompletedNo Results AvailablePrimary Peritoneal Carcinoma|Recurrent Ovarian CarcinomaOther: Laboratory Biomarker Analysis|Drug: Sorafenib Tosylatehttps://ClinicalTrials.gov/show/NCT00093626
187843187843Sorafenib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNo Results AvailableAdult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain TumorDrug: sorafenib tosylate|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00093613
187844187844PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNo Results AvailableAcute Myeloid Leukemia (AML)Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: midostaurinhttps://ClinicalTrials.gov/show/NCT00093600
187845187845Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableGraft Versus Host Disease|LeukemiaBiological: anti-thymocyte globulin|Drug: busulfan|Drug: cyclophosphamide|Drug: cyclosporine|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00093587
187846187846Lycopene in Preventing Prostate Cancer in Healthy ParticipantsCompletedNo Results AvailableProstate CancerDietary Supplement: lycopenehttps://ClinicalTrials.gov/show/NCT00093561
187847187847Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver CancerWithdrawnNo Results AvailableLiver CancerBiological: alpha fetoprotein adenoviral vector vaccine|Biological: alpha fetoprotein plasmid DNA vaccine|Biological: sargramostim plasmid DNA hepatocellular carcinoma vaccine adjuvanthttps://ClinicalTrials.gov/show/NCT00093548
187848187848Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney CancerActive, not recruitingNo Results AvailableKidney CancerBiological: autologous tumor cell vaccine|Biological: keyhole limpet hemocyanin|Biological: therapeutic autologous dendritic cells|Drug: fludarabine phosphate|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00093522
187849187849MRI Sarcoma Non Invasive ThermometryCompletedNo Results AvailableSarcomaDrug: doxorubicin hydrochloride|Drug: ifosfamide and mesna|Procedure: hyperthermia treatment with an MRI Compatible Radiofrequency Extremity Hyperthermia Applicator|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00093509
187850187850Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity CancerCompletedHas ResultsPrimary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial CancerDrug: gemcitabine hydrochloride|Drug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00093496
187851187851Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaBiological: filgrastim|Drug: arsenic trioxide|Drug: cytarabine|Drug: idarubicinhttps://ClinicalTrials.gov/show/NCT00093483
187852187852Tipifarnib in Treating Patients With Acute Myeloid Leukemia in RemissionActive, not recruitingNo Results AvailableAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult AcutProcedure: Clinical Observation|Drug: Tipifarnibhttps://ClinicalTrials.gov/show/NCT00093470
187853187853Sorafenib in Treating Patients With Metastatic or Recurrent Prostate CancerCompletedNo Results AvailableProstate CancerDrug: sorafenib tosylatehttps://ClinicalTrials.gov/show/NCT00093457
187854187854Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver TumorsCompletedNo Results AvailableLiver Cancer|Metastatic CancerDrug: lyso-thermosensitive liposomal doxorubicin|Procedure: radiofrequency ablationhttps://ClinicalTrials.gov/show/NCT00093444
187855187855S0432 Tipifarnib in Treating Older Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableAdult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute MyeloblastDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00093418
18785618785617-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney CancerCompletedNo Results AvailableKidney CancerDrug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00093405
187857187857Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerCompletedHas ResultsAnal CancerDrug: Capecitabine|Drug: Oxaliplatin|Radiation: Radiation Therapy (XRT)https://ClinicalTrials.gov/show/NCT00093379
187858187858Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNo Results AvailableLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative DiseasesBiological: etanercept|Drug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00093366
187859187859N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNo Results AvailableDiarrhea|Drug/Agent Toxicity by Tissue/Organ|NeuroblastomaDrug: cefixime|Drug: irinotecan hydrochloride|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00093353
187860187860Acupuncture for Irritable Bowel Syndrome (IBS)CompletedNo Results AvailableIrritable Bowel SyndromeProcedure: Acupuncturehttps://ClinicalTrials.gov/show/NCT00093327

* Görseller ve İçerik tekif hakkına sahip olabilir